Nanoviricides Overview
- Year Founded
-
2005
- Status
-
Public
- Employees
-
7
- Stock Symbol
-
NNVC
- Investments
-
2
- Share Price
-
$1.42
- (As of Friday Closing)
Nanoviricides General Information
Description
Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.
Contact Information
Website
www.nanoviricides.comCorporate Office
- 1 Controls Drive
- Suite 205
- Shelton, CT 06484
- United States
Corporate Office
- 1 Controls Drive
- Suite 205
- Shelton, CT 06484
- United States
Nanoviricides Stock Performance
As of 25-Apr-2025, Nanoviricides’s stock price is $1.42. Its current market cap is $22.2M with 15.6M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $1.42 | $1.35 | $0.94 - $3.59 | $22.2M | 15.6M | 202K | -$0.71 |
Nanoviricides Financials Summary
As of 31-Dec-2024, Nanoviricides has a trailing 12-month revenue of null.
|
In Thousands, USD |
TTM 31-Dec-2024 | FY 2024 30-Jun-2024 | FY 2023 30-Jun-2023 | FY 2022 30-Jun-2022 |
|---|---|---|---|---|
| EV | 16,650 | 17,063 | 3,765 | 6,315 |
| Revenue | 0 | 0 | 0 | 0 |
| EBITDA | (8,755) | (7,757) | (8,196) | (7,390) |
| Net Income | (9,365) | (8,294) | (8,589) | (8,107) |
| Total Assets | 11,571 | 12,823 | 16,900 | 23,495 |
| Total Debt | 0 | 0 | 0 | 95 |
Nanoviricides Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Nanoviricides Comparisons
Industry
Financing
Details
Nanoviricides Competitors (26)
One of Nanoviricides’s 26 competitors is Dicerna Pharmaceuticals, a Formerly VC-backed company based in Lexington, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Dicerna Pharmaceuticals | Formerly VC-backed | Lexington, MA | ||||
| Anavex Life Sciences | Corporation | New York, NY | ||||
| Alnylam Pharmaceuticals | Formerly VC-backed | Cambridge, MA | ||||
| BioCryst Pharmaceuticals | Corporation | Durham, NC | ||||
| Regulus Therapeutics | Formerly VC-backed | San Diego, CA |
Nanoviricides Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Nanoviricides Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Nanoviricides Investments & Acquisitions (2)
Nanoviricides’s most recent deal was a Corporate Asset Purchase with Inno-Haven (cGMP-compliant Manufacturing and R&D facility). The deal was made on 07-Jan-2015.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Inno-Haven (cGMP-compliant Manufacturing and R&D facility) | 07-Jan-2015 | Corporate Asset Purchase | Buildings and Property | ||
| Edot-com.com | 01-Jun-2005 | Merger/Acquisition | Internet Retail |
Nanoviricides ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
Nanoviricides FAQs
-
When was Nanoviricides founded?
Nanoviricides was founded in 2005.
-
Where is Nanoviricides headquartered?
Nanoviricides is headquartered in Shelton, CT.
-
What is the size of Nanoviricides?
Nanoviricides has 7 total employees.
-
What industry is Nanoviricides in?
Nanoviricides’s primary industry is Biotechnology.
-
Is Nanoviricides a private or public company?
Nanoviricides is a Public company.
-
What is Nanoviricides’s stock symbol?
The ticker symbol for Nanoviricides is NNVC.
-
What is the current stock price of Nanoviricides?
As of 25-Apr-2025 the stock price of Nanoviricides is $1.42.
-
What is the current market cap of Nanoviricides?
The current market capitalization of Nanoviricides is $22.2M.
-
Who are Nanoviricides’s competitors?
Dicerna Pharmaceuticals, Anavex Life Sciences, Alnylam Pharmaceuticals, BioCryst Pharmaceuticals, and Regulus Therapeutics are some of the 26 competitors of Nanoviricides.
-
What is Nanoviricides’s annual earnings per share (EPS)?
Nanoviricides’s EPS for 12 months was -$0.71.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
